AAAAAA

   
Results: 1-20 |
Results: 20
MOLECULAR PATHOLOGICAL SUBSTAGING IN 244 STAGE-I NON-SMALL-CELL LUNG-CANCER PATIENTS - CLINICAL IMPLICATIONS
Authors: KWIATKOWSKI DJ HARPOLE DH GODLESKI J HERNDON JE SHIEH DB RICHARDS W BLANCO R XU HJ STRAUSS GM SUGARBAKER DJ
Citation: Dj. Kwiatkowski et al., MOLECULAR PATHOLOGICAL SUBSTAGING IN 244 STAGE-I NON-SMALL-CELL LUNG-CANCER PATIENTS - CLINICAL IMPLICATIONS, Journal of clinical oncology, 16(7), 1998, pp. 2468-2477
CLINICAL RADIATION PNEUMONITIS AND RADIOGRAPHIC CHANGES AFTER THORACIC RADIATION-THERAPY FOR LUNG-CARCINOMA
Authors: MONSON JM STARK P REILLY JJ SUGARBAKER DJ STRAUSS GM SWANSON SJ DECAMP MM MENTZER SJ BALDINI EH
Citation: Jm. Monson et al., CLINICAL RADIATION PNEUMONITIS AND RADIOGRAPHIC CHANGES AFTER THORACIC RADIATION-THERAPY FOR LUNG-CARCINOMA, Cancer, 82(5), 1998, pp. 842-850
PROGNOSTIC MARKERS IN RESECTABLE NONSMALL CELL LUNG-CANCER
Authors: STRAUSS GM
Citation: Gm. Strauss, PROGNOSTIC MARKERS IN RESECTABLE NONSMALL CELL LUNG-CANCER, Hematology/oncology clinics of North America, 11(3), 1997, pp. 409
IFOSFAMIDE CARBOPLATIN/ETOPOSIDE/PACLITAXEL IN ADVANCED LUNG-CANCER -UPDATE AND PRELIMINARY SURVIVAL ANALYSIS/
Authors: STRAUSS GM LYNCH TJ ELIAS AD JACOBS C HERBST R LEONG T LYNCH C KWIATKOWSKI DJ CAREY RW GROSSBARD ML SKARIN AT
Citation: Gm. Strauss et al., IFOSFAMIDE CARBOPLATIN/ETOPOSIDE/PACLITAXEL IN ADVANCED LUNG-CANCER -UPDATE AND PRELIMINARY SURVIVAL ANALYSIS/, Seminars in oncology, 24(4), 1997, pp. 73-80
MEASURING EFFECTIVENESS OF LUNG-CANCER SCREENING - FROM CONSENSUS TO CONTROVERSY AND BACK
Authors: STRAUSS GM
Citation: Gm. Strauss, MEASURING EFFECTIVENESS OF LUNG-CANCER SCREENING - FROM CONSENSUS TO CONTROVERSY AND BACK, Chest, 112(4), 1997, pp. 216-228
WOMEN AND LUNG-CANCER - WAITING TO EXHALE
Authors: BALDINI EH STRAUSS GM
Citation: Eh. Baldini et Gm. Strauss, WOMEN AND LUNG-CANCER - WAITING TO EXHALE, Chest, 112(4), 1997, pp. 229-234
SCREENING FOR LUNG-CANCER - ANOTHER LOOK - A DIFFERENT VIEW
Authors: STRAUSS GM GLEASON RE SUGARBAKER DJ
Citation: Gm. Strauss et al., SCREENING FOR LUNG-CANCER - ANOTHER LOOK - A DIFFERENT VIEW, Chest, 111(3), 1997, pp. 754-768
PATTERNS OF FAILURE AFTER TRIMODALITY THERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA
Authors: BALDINI EH RECHT A STRAUSS GM DECAMP MM SWANSON SJ LIPTAY MJ MENTZER SJ SUGARBAKER DJ
Citation: Eh. Baldini et al., PATTERNS OF FAILURE AFTER TRIMODALITY THERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA, The Annals of thoracic surgery, 63(2), 1997, pp. 334-338
CHEST-WALL INVASIVE NON-SMALL-CELL LUNG-CANCER - PATTERNS OF FAILURE AND IMPLICATIONS FOR A REVISED STAGING SYSTEM
Authors: HARPOLE DH HEALEY EA DECAMP MM MENTZER SJ STRAUSS GM SUGARBAKER DJ
Citation: Dh. Harpole et al., CHEST-WALL INVASIVE NON-SMALL-CELL LUNG-CANCER - PATTERNS OF FAILURE AND IMPLICATIONS FOR A REVISED STAGING SYSTEM, Annals of surgical oncology, 3(3), 1996, pp. 261-269
EXTRAPLEURAL PNEUMONECTOMY IN THE MULTIMODALITY THERAPY OF MALIGNANT PLEURAL MESOTHELIOMA - RESULTS IN 120 CONSECUTIVE PATIENTS
Authors: SUGARBAKER DJ GARCIA JP RICHARDS WG HARPOLE DH HEALYBALDINI E DECAMP MM MENTZER SJ LIPTAY MJ STRAUSS GM SWANSON SJ
Citation: Dj. Sugarbaker et al., EXTRAPLEURAL PNEUMONECTOMY IN THE MULTIMODALITY THERAPY OF MALIGNANT PLEURAL MESOTHELIOMA - RESULTS IN 120 CONSECUTIVE PATIENTS, Annals of surgery, 224(3), 1996, pp. 288-294
MOLECULAR AND PATHOLOGICAL MARKERS IN STAGE-I NON-SMALL-CELL CARCINOMA OF THE LUNG
Authors: STRAUSS GM KWIATKOWSKI DJ HARPOLE DH LYNCH TJ SKARIN AT SUGARBAKER DJ
Citation: Gm. Strauss et al., MOLECULAR AND PATHOLOGICAL MARKERS IN STAGE-I NON-SMALL-CELL CARCINOMA OF THE LUNG, Journal of clinical oncology, 13(5), 1995, pp. 1265-1279
AN HISTORICAL-PERSPECTIVE OF MULTIMODALITY TREATMENT FOR RESECTABLE NONSMALL CELL LUNG-CANCER
Authors: JAKLITSCH MT STRAUSS GM HEALEY EA DECAMP MM LIPTAY MJ SUGARBAKER DJ
Citation: Mt. Jaklitsch et al., AN HISTORICAL-PERSPECTIVE OF MULTIMODALITY TREATMENT FOR RESECTABLE NONSMALL CELL LUNG-CANCER, Lung cancer, 12, 1995, pp. 17-32
A PHASE-I STUDY OF IFOSFAMIDE CARBOPLATIN ETOPOSIDE PACLITAXEL IN ADVANCED LUNG-CANCER
Authors: STRAUSS GM LYNCH TJ ELIAS AD JACOBS C KWIATKOWSKI DJ SHULMAN LN CAREY RW GROSSBARD ML JAUSS S SUGARBAKER DJ SKARIN AT
Citation: Gm. Strauss et al., A PHASE-I STUDY OF IFOSFAMIDE CARBOPLATIN ETOPOSIDE PACLITAXEL IN ADVANCED LUNG-CANCER, Seminars in oncology, 22(4), 1995, pp. 70-74
UNTITLED
Authors: STRAUSS GM
Citation: Gm. Strauss, UNTITLED, Chest, 108(6), 1995, pp. 1770-1772
CHEST-X-RAY SCREENING IMPROVES OUTCOME IN LUNG-CANCER - A REAPPRAISALOF RANDOMIZED TRIALS ON LUNG-CANCER SCREENING
Authors: STRAUSS GM GLEASON RE SUGARBAKER DJ
Citation: Gm. Strauss et al., CHEST-X-RAY SCREENING IMPROVES OUTCOME IN LUNG-CANCER - A REAPPRAISALOF RANDOMIZED TRIALS ON LUNG-CANCER SCREENING, Chest, 107(6), 1995, pp. 270-279
USE OF TUMOR-MARKERS IN LUNG-CANCER
Authors: STRAUSS GM SKARIN AT
Citation: Gm. Strauss et At. Skarin, USE OF TUMOR-MARKERS IN LUNG-CANCER, Hematology/oncology clinics of North America, 8(3), 1994, pp. 507-532
NODE STATUS HAS PROGNOSTIC-SIGNIFICANCE IN THE MULTIMODALITY THERAPY OF DIFFUSE, MALIGNANT MESOTHELIOMA
Authors: SUGARBAKER DJ STRAUSS GM LYNCH TJ RICHARDS W MENTZER SJ LEE TH CORSON JM ANTMAN KH
Citation: Dj. Sugarbaker et al., NODE STATUS HAS PROGNOSTIC-SIGNIFICANCE IN THE MULTIMODALITY THERAPY OF DIFFUSE, MALIGNANT MESOTHELIOMA, Journal of clinical oncology, 11(6), 1993, pp. 1172-1178
NEOADJUVANT AND ADJUVANT THERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: JAKLITSCH MT STRAUSS GM SUGARBAKER DJ
Citation: Mt. Jaklitsch et al., NEOADJUVANT AND ADJUVANT THERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER, World journal of surgery, 17(6), 1993, pp. 729-734
ADVANCES IN SURGICAL STAGING AND THERAPY OF NON-SMALL-CELL LUNG-CANCER
Authors: SUGARBAKER DJ STRAUSS GM
Citation: Dj. Sugarbaker et Gm. Strauss, ADVANCES IN SURGICAL STAGING AND THERAPY OF NON-SMALL-CELL LUNG-CANCER, Seminars in oncology, 20(2), 1993, pp. 163-172
MULTIMODALITY THERAPY OF PATIENTS WITH STAGE-IIIA, N2 NON-SMALL-CELL LUNG-CANCER - IMPACT OF PREOPERATIVE CHEMOTHERAPY ON RESECTABILITY ANDDOWNSTAGING
Authors: KIRN DH LYNCH TJ MENTZER SJ LEE TH STRAUSS GM ELIAS AD SKARIN AT SUGARBAKER DJ
Citation: Dh. Kirn et al., MULTIMODALITY THERAPY OF PATIENTS WITH STAGE-IIIA, N2 NON-SMALL-CELL LUNG-CANCER - IMPACT OF PREOPERATIVE CHEMOTHERAPY ON RESECTABILITY ANDDOWNSTAGING, Journal of thoracic and cardiovascular surgery, 106(4), 1993, pp. 696-702
Risultati: 1-20 |